Monograph
S01BC11 - Bromfenac |
Not porphyrinogenic |
NP |
Rationale
Bromfenac is administered locally in the eye and plasma concentrations are not quantifiable. The hepatic exposure is insignificant
Chemical description
Benzophenone
Therapeutic characteristics
Bromfenac is an anti-inflammatory agent used in the treatment of postoperative ocular inflammation following cataract extraction in adults. One drop is administered in the eye twice daily in two weeks after cataract extraction (SPC).
Hepatic exposure
Bromfenac has not been detected in plasma after ocular administration (SPC).
Metabolism and pharmacokinetics
In vitro studies indicate that bromfenac is metabolized by CYP2C9 (SPC).
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Yellox.
|
|
Tradenames
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Bromfenac · Yellox 
Yellox 
Yellox 
Brofestill · Infladrop · Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Yellox 
Bromfenaco 
Bromfenac